Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Nov 20.
Published in final edited form as: J Evid Based Med. 2016 May 20;9(3):116–124. doi: 10.1111/jebm.12204

Effect of Hatha Yoga on Anxiety: A Meta-Analysis

Stefan G Hofmann 1, Giovanbattista Andreoli 1, Joseph K Carpenter 1, Joshua Curtiss 1
PMCID: PMC5116432  NIHMSID: NIHMS788847  PMID: 27203378

Abstract

Objective

Some evidence suggests that Hatha yoga might be an effective practice to reduce anxiety. To examine the effect of Hatha yoga on anxiety, we conducted a meta-analysis of relevant studies extracted from PubMed, PsycINFO, the Cochrane Library, and manual searches.

Methods

The search identified 17 studies (11 waitlist controlled trials) totaling 501 participants who received Hatha yoga and who reported their levels of anxiety before and after the practice. We estimated the controlled and within-group random effects of the practice on anxiety.

Results

The pre-post within-group and controlled effect sizes were, Hedges’ g = 0.44 and Hedges’ g = 0.61, respectively. Treatment efficacy was positively associated with the total number of hours practiced. People with elevated levels of anxiety benefitted the most. Effect sizes were not moderated by study year, gender, presence of a medical disorder, or age. Although the quality of the studies was relatively low, the risk of study bias did not moderate the effect.

Conclusions

Hatha yoga is a promising method for treating anxiety. However, more well-controlled studies are needed to compare the efficacy of Hatha yoga with other more established treatments and to understand its mechanism.

Keywords: Anxiety, Complementary Therapies, Meta-analysis, Systematic Review, Yoga

Introduction

Anxiety and its disorders are common mental health problems that are associated with high comorbidity, suffering, and societal burden (1). Recently, mindfulness practices have shown some promise for reducing anxiety symptoms (2, 3). However, these treatments are still not widely disseminated. In contrast, yoga, which shares many similarities to psychological mindfulness-based treatments, is more readily available and its popularity is increasing. In fact, Yoga has been adopted by the advertising industry as a symbol of health and a wholesome lifestyle. Based on a 2007 National Health Interview Survey (NHIS), yoga was the sixth most commonly used complementary health practice among adults, and between the 2002 and 2007 NHIS, use of yoga among adults increased by 1 percent or approximately 3 million people (4). The most commonly practiced form of yoga in the USA is Hatha yoga (5). Meditation is a core component of this yoga practice, both historically and in practice. This notion is consistent with the definition of Hatha yoga by the National Center for Complementary and Integrative Health (6), which considers meditation an important component next to physical postures, breathing exercises, and a distinct philosophy as of yoga.

Despite its popularity, no quantitative review of Hatha yoga as a possible treatment for anxiety exists. Therefore, the goal of the present study was to provide a systematical review of the efficacy of yoga for reducing anxiety symptoms. Although there are many different forms of yoga practices, we limited our review the Hatha yoga, the most common form of yoga practice. We tested the hypothesis that Hatha yoga is an effective treatment for reducing symptoms of anxiety.

Methods

Search

A search of PubMed, PsycINFO and Cochrane Library databases was conducted on September 18, 2015. The following search terms were used: yoga AND (anxiety OR anxious OR panic OR agoraphobia OR social phobia OR social anxiety OR sad OR generalized anxiety OR gad OR obsessive compulsive OR obsessive-compulsive OR ocd OR specific phobia OR simple phobia OR post-traumatic stress OR post-traumatic stress OR posttraumatic stress OR ptsd OR acute stress OR asd). The initial search produced 2 234 results, with 946 studies remaining after duplicates and resources reporting data presented in another selected study were excluded. In accordance with the guidelines set forth in Preferred Reporting Items for Systematic Reviews and Meta-analysis Protocols (7) the protocol for this meta-analyses was registered in with the International Prospective Register of Systematic Reviews (PROSPERO) on September 9, 2015, and was last updated on February 2, 2016 (registration number CRD42015026303).

Study Selection

Studies were included in the present meta-analysis if: 1) at least one treatment condition consisted of a course of Hatha yoga (i.e. no single-session interventions); 2) they included an adequate measure of anxiety at pre- and post-intervention; 3) they included a sample of adults 18 years or older; and 4) they provided sufficient data on the intervention of interest for calculating an effect size to use in our meta-analysis.

Studies were excluded if: 1) the bibliographic resource was a review, a meta-analysis, a survey, a manual or a conference abstract; 2) Hatha yoga was not described as “pure” Hatha, meaning: a) the authors explicitly define that just one or some component of Hatha yoga were used (e.g. only breathing or poses); b) Hatha yoga was defined as explicitly and drastically modified from the traditional method, with the introduction of not-conventional procedures; or c) the yoga descriptions were too ambiguous to define the yoga style as Hatha; 3) Hatha yoga was administered in conjunction with another active treatment. In cases of disagreement, the authors discussed the case until consensus was reached. If a study met all other inclusion criteria, but the data necessary to calculate an effect size were not reported, we emailed the corresponding author to request the necessary data to conduct the analyses.

Data Extraction

For each selected study, the second author and four independent trained assessors extracted data on anxiety measures at pre-treatment and post-treatment for the Hatha yoga arms, along with data from non-active control conditions if included. In addition, we extracted data on sample and study characteristics, including sample size, duration and frequency of treatment, gender distribution, age, and whether the sample consisted of a medical population, and publication year. Because there is no standardized protocol for the delivery of Hatha yoga, we also identified and extracted the components of the interventions as described by the authors of each study, which included yoga postures, breathing techniques, relaxation, meditation, and other techniques such as mindfulness or acceptance. Data were extracted on two separate occasions by independent raters and compared to ensure reliability, with discrepancies resolved by the second author.

Risk of Bias Assessment

In accordance with the Cochrane guidelines for systematic reviews (8), we assessed study quality with the Cochrane Collaboration’s tool for assessing risk of bias (9). This tool involves assessing each study as containing a high, low or unclear level of bias risk in a number of domains using pre-specified criteria. The domains used in our assessment were: 1) Sequence Generation, which assesses whether allocation of participants to treatment condition are adequately generated in a random manner; 2) Allocation Concealment, which assesses whether treatment assignment was adequately concealed from investigators and participants prior to randomization; 3) Incomplete Outcome Data, which assesses whether outcome data are missing at random and imputed using appropriate methods; and 4) Selective Outcome Reporting, which determines whether pre-specified outcome variables of interest are adequately and completely reported. Although this tool was initially designed for assessment of randomized controlled trials, the Cochrane guidelines specify that it may be adapted for the evaluation of non-randomized trials (8). In doing so, we assigned non-randomized trials a high risk rating in the sequence generation category. Following recommendations from the Cochrane guidelines, a total bias assessment was created for each study such that an ‘unclear’ rating in any category meant an ‘unclear risk’ overall rating unless there was a ‘high’ rating in any category, which lead to a ‘high risk’ overall rating. ‘Low risk’ studies had to be rated as ‘low’ in all four categories. The third and fourth authors independently rated each study and then met to resolve any discrepancies. Inter-rater reliability for the total bias assessment was strong (Kappa = .74; SE = .17).

Data Analyses

The meta-analytic procedures were conducted in Comprehensive Meta-Analysis, Version 3. We used a random effects model because of the heterogeneity within the studies. Within-group and controlled effect sizes were calculated using Hedges’ g (10).

To investigate potential moderator effects on outcome, we employed the between-group heterogeneity statistic (QB) recommended by Hedges and Olkin (10) and meta-regression procedures for categorical and continuous moderators, respectively. Moderators of interest included both study procedure characteristics (i.e., number of sessions, session frequency, study quality, study year) and sample characteristics (i.e., age, sex, presence of a medical condition).

To examine the presence of publication bias, we used the fail-safe N method to determine the number of additional studies with a null result needed to reduce the overall effect size to non-significance (11). We also examined the funnel plot to evaluate symmetry relative to the mean effect size, with greater symmetry corresponding to decreased likelihood of publication bias. To complement funnel plot inspection, the trim and fill method (12) was utilized to determine the nature of potential publication bias and compute an imputed effect size that accounts for such bias.

Results

Study Characteristics

Figure 1 shows the number of studies excluded at each stage of study selection, and the reasons for exclusion. Of the 2 234 studies initially identified, 17 were determined to be eligible (1329). Together these studies examined the effect of yoga on anxiety symptoms in 501 participants. Eleven of these studies contained waitlist controls allowing for the calculation of a between-groups effect size.

Figure 1. Flow diagram of study selection process.

Figure 1

aOf the 17 studies, 11 included a comparison between a non-active control group and a Hatha yoga group.

Study characteristics are presented in Table 1. Results from the risk of bias assessment showed that seven studies had an unclear risk of bias, nine had a high risk of bias, and one study had a low risk of bias. Across studies, the mean study sample consisted of 75.5% female participants (SD = 31.81), and had a mean age of the 41.08 (SD = 12.42). Mean treatment duration was 8.69 weeks (SD = 4.17), and mean session frequency was 2.25 times per week (SD = 1.31). All 14 of the studies that provided descriptions of the Hatha yoga included postures, and 13 of the 14 studies included breathing techniques. Five of the studies described using relaxation techniques, seven described the use of meditation, and two studies included other components (mindfulness and awareness/acceptance exercises).

Table 1.

Study Characteristics

Study Hatha Yoga Components
RCT Length of
Treatment
(weeks)
Sessions per
week
Sample Size Female (%) Mean Age
(SD)
Sample Risk of Bias
Post Brea Relax Medit Oth SG AC ID SR Total
Ahmadi 2013 (13) Yes 8 3 11 100 32.3 (8.7) Multiple Sclerosis patients ? ? ? ?
Baker 1979 (14) Yes 4 2 20 75 NA General population ? ? ? ?
Bernardi 2013 (15) NA Yes 2 3 26 100 49 (NA) Mastectomy patients ? ? ?
Bunk 1978 (16) Yes 5 3 14 0 27.7 (NA) Prison inmates X ? ? X
Cheema 2013 (17) Yes 10 3 18 78 37 (12) University employees ? ?
Cramer 2015 (18) Yes 10 1 27 37 68.7 (9.1) Colorectal cancer survivors
Curtis 2011 (19) a No 8 2 22 100 47.4 (13.7) Fibromyalgia patients X ? ? X
Dunn 2009 (20) No 6 1 6 100 48.7 (14.4) Health care employees X ? ? X
Holmer 2004 (21) b No 8 2 29 90 44.7 (13.2) Fibromyalgia patients X ? X X
Moadel 2007 (22) Yes 12 1 84 100 55.1 (10.7) Breast cancer patients ? X X
Pavan 1992 (23) NA No NA NA 18 100 31 (NA) General population ? ? ? X X
Ray 2001 (24) Yes 20 3 28 18 23.4 (0.6) Engineering trainees ? ? ? ?
Ruggiero 2006 (25) No 8 1 19 NA 41.4 (18.5) University students X ? X X
Sujatha 2014 (26) Yes 12 5 118 53 30–60 (NA) Hypertension patients ? ? ? ? ?
Vizcaino 2013 (27) No 6 3 10 80 61.4 (6.7) Type 2 diabetes mellitus patients X ? ? X
Vorkapic 2014 (28) Yes 8 2 10 90 42.3 (7.5) Panic disorder patients ? ? ? ?
Yoo 2007 (29) NA No 12 1 41 87 47 (13.6) University students X X ? X

Definitions of abbreviations are listed below:

Hatha Yoga Components: Post = Postures; Brea = Breathing techniques; Relax = Relaxation techniques; Medit = Meditation; Oth = Other techniques;

a

mindfulness exercise,

b

awareness and acceptance exercise);

NA = No description of treatment components available

Risk of Bias: SG = Sequence Generation; AC = Allocation Concealment; ID = Incomplete Outcome Data; SR = Selective Outcome Reporting; X = High Risk of Bias; ? = Unclear Risk of Bias; ✓ = Low Risk of Bias.

Eight of the 17 studies examined the effect of yoga on anxiety in a sample with a medical condition, and one study examined a sample with a psychological condition (panic disorder). To assess the baseline anxiety severity of each study sample, we compared mean anxiety scores at pre-test to population norms and clinical cut-offs whenever possible (Table 2). Of the 13 studies that included anxiety measures where norms and clinical cut-offs were available, four used samples with mean anxiety scores above the clinical cut-off, and an additional three studies had samples with elevated anxiety levels that were significantly greater than population means. Population means and clinical cut-offs for the measures where such data were available were as follows: State Trait Anxiety Inventory – Trait (STAI; 31): population mean = 36.35 (SD = 11.39; 39), clinical cut-off ≥46 (40); Beck Anxiety Inventory (BAI; 30): population mean = 6.16 (SD = 7.16; 39), clinical cut-off ≥16 (30); Hospital Anxiety and Depression Scale - anxiety subscale (HADS-A; 32): population mean = 4.7 (SD = 3.5; 41), clinical cut-off ≥8 (42); Hamilton Anxiety Rating Scale (HAM-A; 38): ≥24 suggests severe anxiety (43); Depression Anxiety and Stress Scales (21 item version) – Anxiety subscale (DASS21-A; 37): population mean = 1.74 (SD = 2.78; 39), clinical cut-off ≥6 (44).

Table 2.

Mean Baseline Anxiety Severity for Included Studies

Study Anxiety Measure Sample Mean at Baseline (SD) Baseline Anxiety Severity
Baker 1979 (14) STAI 38.95 (11.54) Normal
Bernardi 2013 (15) 44.31 (10.15)** Elevated
Bunk 1978 (16) 36.64 (7.5) Normal
Cheema2013 (17) 36.1 (10.4) Normal
Ruggiero 2006 (25) 39.93 (8.84) Normal
Sujatha2014 (26) 46.31 (9.05)** Clinical
Vizcaino 2013 (27) 36.8 (11.22) Normal

Ahmadi 2013 (13) BAI 12.45 (4.54)* Elevated
Dunn 2009 (14) 18.96 (11.83)** Clinical

Cramer 2015 (18) HADS-A 5.00 (2.08) Normal
Curtis 2011 (19) 10.83 (4.4)** Clinical

Vorkapic 2014 (28) HAM-A 31.45 (1.7) Clinical

Yoo 2007 (29) DASS-A 4.61 (5.25)** Elevated

Holmer 2005 (21) AIMS2-A 16.83 (3.16) NA+

Moadel 2007 (22) DMI-AS 9.70 (8.11) NA+

Pavan 1982 (23) 16PF-A 7.7 (NA) NA+

Ray 2001 (24) IPAT-A 28.77 (8.80) NA+
*

Significantly different from population mean (unpaired t-test) at p < .01;

**

p < .001;

+

population means and clinical cut-offs not available

Anxiety Measures: BAI = Beck Anxiety Inventory (30); STAI = State-Trait Anxiety Inventory (31); HADS-A = Hospital Anxiety and Depression Scale-anxiety subscale (32); AIMS2-A = Arthritis Impact Measurement Scales Revised – Anxiety subscale (33); DMI-AS = Distressed Mood Index - Anxious/Sadness factor (34); 16-PF = 16 Personality Factor Questionnaire -Anxiety subscale (35); IPAT-A = IPAT Anxiety Scale Questionnaire (36); DASS21-A = Depression Anxiety and Stress Scales (21 item version) - Anxiety subscale (37); HAM-A = Hamilton Anxiety Rating Scale (38).

Quantitative Data Synthesis

Within-group effect sizes

a) Pre-post within-group effects

Within-group effect sizes, confidence intervals and significance values for each study are presented in Table 3. For the within-group analysis, one outlier (Hedges’ g = 5.63) was identified (28) and removed from subsequent analyses. The random effects meta-analysis yielded an overall effect size on anxiety of Hedges’ g = 0.44 (95% CI: 0.25–0.63, z = 4.491, P < .001). The fail-safe N analysis for the within-group effect size was robust with N = 432 (z = 10.36). Inspection of the funnel plot reveals a distribution of effect sizes concentrated to the left of the mean effect size, which indicates a decreased likelihood of publication bias from small studies with disproportionately large effect sizes (Figure 2). Using the Trim and Fill method (12), no studies would need to fall to the left of the mean (i.e., have an effect size smaller than the mean) and 2 studies would need to fall to the right of the mean (i.e., have an effect size larger than the mean) to make the plot symmetrical, suggesting that the computed effect size is a conservative estimate. The random-effects model for the new imputed mean effect size revealed a Hedges’ g = 0.69 (95% CI: 0.41–0.56).

Table 3.

Hedges’ g for within-group pre-post, and controlled pre-post anxiety effect sizes in each study

Study Pre-Post Effect Size Pre-Post Control. Effect Size

Hedges’ g (95% CI) Z P Hedges’ g (95% CI) Z P
Ahmadi 2013 (13) 1.31 (0.71, 1.91) 4.29 0.00 1.44 (0.51, 2.37) 3.03 0.00
Baker 1979 (14) 0.32 (−0.02, 0.65) 1.87 0.06 0.53 (−0.06, 1.12) 1.76 0.08
Bernardi 2013 (15) 0.88 (0.44, 1.32) 3.89 0.00 1.27 (0.63, 1.91) 3.91 0.00
Bunk 1978 (16) 0.37 (−0.03, 0.76) 1.81 0.07 0.41 (−0.27, 1.08) 1.18 0.24
Cheema 2013 (17) 0.28 (−0.07, 0.63) 1.60 0.11 −0.04 (−0.67, 0.59) −0.13 0.89
Cramer 2015 (18) 0.13 (−0.16, 0.42) .89 0.37 0.41 (−0.12, 0.94) 1.51 0.13
Curtis 2011 (19) 0.23 (−0.09, 0.54) 1.41 0.16 - - -
Dunn 2009 (20) 0.75 (0.13, 1.37) 2.38 0.02 - - -
Holmer 2004 (21) 0.39 (−0.03, 0.82) 1.80 0.07 1.13 (0.35, 1.90) 2.85 0.00
Moadel 2007 (22) 0.20 (0.04, 0.37) 2.37 0.02 0.22 (−0.15, 0.58) 1.16 0.25
Pavan 1992 (23) 0.38 (−0.07, 0.84) 1.64 0.10 - - -
Ray 2001 (24) −0.05 (−0.60, 0.49) −.19 0.85 −0.10 (−1.23, 1.02) −0.18 0.86
Ruggiero 2006 (25) 0.25 (−0.09, 0.59) 1.46 0.15 - - -
Sujatha 2014 (26) 1.04 (0.86, 1.21) 11.76 0.00 1.32 (1.04, 1.60) 9.24 0.00
Vizcaino 2013 (27) 0.50 (0.03, 0.98) 2.10 0.04 - - -
Yoo 2007 (29) 0.29 (0.05, 0.52) 2.35 0.02 0.16 (−0.26, 0.59) 0.75 0.46
Subtotal 0.44 (0.25, 0.63) 4.49 0.00 0.61 (0.25, 0.98) 3.32 0.00
Figure 2. Funnel plot of precision by Hedges’ g for quality of life measures in the pooled meta-analysis*.

Figure 2

*This funnel plot reflects a random effects model. Horizontal and vertical axes plot the effect size and standard error of the effect size, respectively.

b) Between-group effect sizes

Between-group effect sizes, confidence intervals and significance values for each study comparing yoga to a waitlist control are presented in Table 3. The between-groups random-effects meta-analysis yielded an overall effect size of Hedges’ g = 0.61 (95% CI: 0.25–0.98, z = 3.32, P = .001). The fail-safe N for this analysis was robust with N = 153 (z = 7.56). The Trim and Fill analysis revealed that no adjustments to the mean effect size was warranted as no studies would need to fall to the left or right of the mean to make the plot symmetrical, suggesting an unbiased effect size estimate.

Moderator Analyses

The results of the meta-regression analysis revealed that treatment efficacy was moderated by the total number of treatment hours (B = 0.005, SE = 0.002, P < 0.05) and number of sessions per week (B = 0.18, SE = 0.05, P < 0.001). Clinical severity status also moderated treatment efficacy (QB = 4.65, df = 2, P < 0.05); studies containing subjects with clinically elevated anxiety symptoms demonstrated greater efficacy (Hedge’s g = 0.72; 95% CI: 0.34–1.09, z = 3.75, P = .001) than did those containing subjects without clinically elevated anxiety symptoms (Hedge’s g = 0.28; 95% CI: 0.13–0.42, z = 3.80, P = .001). Effect sizes were not moderated by study year (B = 0.07, SE = 0.01, P = n.s.), percentage of males (B = −0.004, SE = 0.003, P = n.s.), presence of a medical disorder (B = −0.24, SE = 0.19, P = n.s.), mean age (B = −0.003, SE = 0.006, P = n.s.), or risk of study bias (QB = 4.06, df = 2, P = n.s.).

Discussion

To examine the effect of Hatha yoga on anxiety, we reviewed a total of 2 234 studies. We identified 17 studies (501 participants) that met the study inclusion criteria. The within-group analysis revealed an overall effect size on anxiety of Hedges’ g = 0.44. This effect size was robust with a low likelihood for a publication bias. In fact, the funnel plot analysis suggested that the obtained effect size was a conservative estimate. The imputed mean effect size (Hedges’ g = 0.69) was similar to the between-groups analysis of the studies comparing yoga to a waitlist control yielded a similar sized effect (Hedges’ g = 0.61). These results are consistent with the results of earlier qualitative reviews that reported promising effects of yoga on anxiety (4547).

The moderator analyses suggested that more yoga practices were associated with greater benefits and the higher the level of anxiety at the beginning, the more beneficial the practices were. In fact, people with clinically elevated anxiety symptoms benefitted the most. Effect sizes were not moderated by study year, gender, presence of a medical disorder, and age. Although the quality ratings of the studies were relatively low, the risk of study bias was unlikely to moderate the effect. These findings provide preliminary support for Hatha yoga as a strategy to reduce symptoms of anxiety. However, the effect was relatively small, questioning the use of Hatha yoga as a stand-along treatment strategy for anxiety. Therefore, combining Hatha yoga with other strategies specifically focusing on the maintenance of the anxiety problems (such as the cognitive and behavioral techniques) seems warranted.

A number of limitations should be noted. First, the results are limited by the relatively few well-controlled trials examining the effect of yoga. Better controlled studies are needed to clearly demonstrate the benefits of yoga for anxiety symptoms. The relatively limited number of studies did not allow for meaningful subanalyses to examine the differential effects of yoga on specific anxiety disorder diagnoses or even specific symptoms. Furthermore, the relatively greater benefit among people with elevated or clinical symptoms of anxiety could be the result of the regression to the mean. Waitlist controlled trials provide weak evidence for the efficacy of the active treatment. The gold-standard treatment for anxiety disorders is cognitive behavior therapy (CBT). Although effective, there is clearly room for further improvement (48). Therefore, one possible design for a future trial might be the comparison between CBT, Hatha yoga, a combination, and active placebo condition. Finally, it is unclear what the mechanism is through which yoga improves anxiety symptoms. While Hatha yoga treatment in nearly all of the included studies contained postures and breathing, some studies involved additional treatment components (e.g. meditation, mindfulness), and thus further research is needed to best understand the active ingredients in Hatha yoga for anxiety. Despite these limitations, the results of this meta-analysis provide preliminary support for Hatha yoga as a treatment for anxiety.

Acknowledgments

This study was funded in part by NIH/NCCIH grant R01AT007257.

Footnotes

Conflict of Interest None

References

  • 1.Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602. doi: 10.1001/archpsyc.62.6.593. [DOI] [PubMed] [Google Scholar]
  • 2.Hofmann SG, Sawyer AT, Witt A, Oh D. The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review. J Consult Clin Psychol. 2010;78:169–183. doi: 10.1037/a0018555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Khoury B, Lecomte T, Fortin G, et al. Mindfulness-based therapy: A comprehensive meta-analysis. Clin Psychol Rev. 2013;33:763–71. doi: 10.1016/j.cpr.2013.05.005. [DOI] [PubMed] [Google Scholar]
  • 4.Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008:12. [PubMed] [Google Scholar]
  • 5.Burley M. Hatha-yoga: Its Context, Theory and Practice. Delhi: Motilal Banarsidass Publishers; 2000. [Google Scholar]
  • 6.National Center for Complementary and Integrative Health. [accessed 9 April 2016];Yoga for health. https://nccih.nih.gov/health/yoga/introduction.htm.
  • 7.Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015:349. doi: 10.1136/bmj.g7647. [DOI] [PubMed]
  • 8.Higgins JPT, Green S. [Accessed 1 April 2016];Cochrane handbook for systematic reviews of interventions version 5.1.0. http://handbook.cochrane.org/
  • 9.Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. Higgins JPT, Green S, editors. [Accessed 1 April 2016];Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. http://handbook.cochrane.org/
  • 10.Hedges L, Olkin I. Statistical Methods for Meta-Analysis. Orlando: Academic Press; 1985. [Google Scholar]
  • 11.Rosenthal R. Meta-Analytic Procedures for Social Research, Revised Edition. Newbury Park: Sage Publications; 1991. [Google Scholar]
  • 12.Duval S, Tweedie R. Trim and fill: a simple funnel plot–based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–63. doi: 10.1111/j.0006-341x.2000.00455.x. [DOI] [PubMed] [Google Scholar]
  • 13.Ahmadi A, Arastoo AA, Nikbakht M, Zahednejad S, Rajabpour M. Comparison of the effect of 8 weeks aerobic and yoga training on ambulatory function, fatigue and mood status in MS patients. Iran Red Crescent Med J. 2013;15:449–54. doi: 10.5812/ircmj.3597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Baker MA. The effects of hatha yoga and self-recording on trait anxiety and locus of control [Dissertation] San Diego: United States International University; 1980. [Google Scholar]
  • 15.Bernardi MLD, Amorim MHC, Zandonade E, Santaella DF, Barbosa JDAN. The effects of hatha yoga exercises on stress and anxiety levels in mastectomized women. Ciênc Saúde Coletiva. 2013;18:3621–32. doi: 10.1590/s1413-81232013001200018. [DOI] [PubMed] [Google Scholar]
  • 16.Bunk BE. Effects of hatha yoga and mantra meditation on the psychological health and behavior of incarcerated males [Dissertation] Dallas: University of Texas Health Science Center; 1978. [Google Scholar]
  • 17.Cheema BS, Houridis A, Busch L, et al. Effect of an office worksite-based yoga program on heart rate variability: outcomes of a randomized controlled trial. BMC Complement Altern Med. 2013:13. doi: 10.1186/1472-6882-13-82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Cramer H, Pokhrel B, Fester C, et al. A randomized controlled bicenter trial of yoga for patients with colorectal cancer. Psychooncology. 2015;25:412–20. doi: 10.1002/pon.3927. [DOI] [PubMed] [Google Scholar]
  • 19.Curtis K, Osadchuk A, Katz J. An eight-week yoga intervention is associated with improvements in pain, psychological functioning and mindfulness, and changes in cortisol levels in women with fibromyalgia. J Pain Res. 2011;4:189–201. doi: 10.2147/JPR.S22761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Dunn KD. The Effectiveness of hatha yoga on symptoms of anxiety and related vulnerabilities, mindfulness, and psychological wellbeing in female health care employees [Dissertation] Fairfax: George Mason University; 2009. [Google Scholar]
  • 21.Holmer ML, Gevirtz R, Spira JL, Greenberg MA. The effects of yoga on symptoms and psychosocial adjustment in fibromyalgia syndrome patients [Dissertation] San Diego: Alliant International University; 2004. [Google Scholar]
  • 22.Moadel AB, Shah C, Wylie-Rosett J, et al. Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of life. J Clin Oncol. 2007;25:4387–95. doi: 10.1200/JCO.2006.06.6027. [DOI] [PubMed] [Google Scholar]
  • 23.Pavan A. Anxiety and new technics of control. Min Psich. 1982;23:27–31. [PubMed] [Google Scholar]
  • 24.Ray US, Mukhopadhyaya S, Purkayastha SS, et al. Effect of yogic exercises on physical and mental health of young fellowship course trainees. Indian J Physiol Pharmacol. 2001;45:37–53. [PubMed] [Google Scholar]
  • 25.Ruggiero M. The Effects of Hatha Yoga and Weight Training on Trait and State Anxiety [Dissertation] Minneapolis: Walden University; 2006. [Google Scholar]
  • 26.Sujatha T, Judie A. Effectiveness of a 12-Week Yoga Program on Physiopsychological Parameters in Patients with Hypertension. Int J Pharm Clin Res. 2014;6:329–35. [Google Scholar]
  • 27.Vizcaino M. Hatha yoga practice for type 2 diabetes mellitus patients: a pilot study. Int J Yoga Therap. 2013;23:59–65. [PubMed] [Google Scholar]
  • 28.Vorkapic CF, Rangé B. Reducing the symptomatology of panic disorder: the effects of a yoga program alone and in combination with cognitive-behavioral therapy. Front Psychiatry. 2014;5:1–7. doi: 10.3389/fpsyt.2014.00177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Yoo CZ, Hapkido VS. yoga: Analysis of choice, persistence and psychological benefits. Chicago: Adler School of Professional Psychology; 2007. [Dissertation] [Google Scholar]
  • 30.Beck AT, Steer RA. Beck Anxiety Inventory Manual. San Antonio: Harcourt Brace & Company; 1993. [Google Scholar]
  • 31.Spielberger CD. Manual for the State-Trait Anxiety Inventory. Palo Alto: Consulting Psychologists Press; 1983. [Google Scholar]
  • 32.Zigmund AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70. doi: 10.1111/j.1600-0447.1983.tb09716.x. [DOI] [PubMed] [Google Scholar]
  • 33.Meenan RF, Gertman PM, Mason JH. Measuring health in arthritis: the arthritis impact measurement scales. Arthritis Rheum. 1980;23:146–52. doi: 10.1002/art.1780230203. [DOI] [PubMed] [Google Scholar]
  • 34.McNair D, Lorr M, Droppelman L. Profile of Moods States Manual. San Diego: Educational & Industrial Testing Services; 1971. [Google Scholar]
  • 35.Cattell RB, Eber HW, Tatsuoka MM. Handbook for the 16PF. Champaign: Institute for Personality and Ability Testing; 1970. [Google Scholar]
  • 36.Cattell RB, Scheier IH. Handbook for the IPAT Anxiety Scale Questionnaire: Self Analysis Form. Champaign: Institute for Personality & Ability Testing; 1963. [Google Scholar]
  • 37.Lovibond SH, Lovibond PF. Manual for the Depression Anxiety Stress Scales. University of New South Wales; Australia: 2004. Psychological Foundation Monograph. [Google Scholar]
  • 38.Hamilton M. Diagnosis and rating of anxiety. The Br J Psychiatry. 1969;3:76–9. [Google Scholar]
  • 39.Crawford J, Cayley C, Lovibond PF, Wilson PH, Hartley C. Percentile norms and accompanying interval estimates from an Australian general adult population sample for self-report mood scales (BAI, BDI, CRSD, CES_D, DASS, DASS_21, STAI_X, STAI_Y, SRDS, and SRAS) Aust Psychol. 2011;46:3–14. [Google Scholar]
  • 40.Fisher PL, Durham RC. Recovery rates in generalized anxiety disorder following psychological therapy: an analysis of clinically significant change in the STAI-T across outcome studies since 1990. Psychol Med. 1999;29:1425–34. doi: 10.1017/s0033291799001336. [DOI] [PubMed] [Google Scholar]
  • 41.Hinz A, Brähler E. Normative values for the Hospital Anxiety and Depression Scale (HADS) in the general German population. J Psychosom Res. 2011;71:74–8. doi: 10.1016/j.jpsychores.2011.01.005. [DOI] [PubMed] [Google Scholar]
  • 42.Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52:69–77. doi: 10.1016/s0022-3999(01)00296-3. [DOI] [PubMed] [Google Scholar]
  • 43.Matza LS, Morlock R, Sexton C, Malley K, Feltner D. Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder. Int J Methods Psychiatr Res. 2010;19:223–32. doi: 10.1002/mpr.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ronk FR, Korman JR, Hooke GR, Page AC. Assessing clinical significance of treatment outcomes using the DASS-21. Psychol Assessment. 2013;25:1103–10. doi: 10.1037/a0033100. [DOI] [PubMed] [Google Scholar]
  • 45.Khalsa SBS. Yoga as a therapeutic intervention: A bibliometric analysis of published research studies. Indian J Physiol Pharmacol. 2004;48:269–85. [PubMed] [Google Scholar]
  • 46.Kirkwood G, Rampes H, Tuffrey V, Richardson J, Pilkington K. Yoga for anxiety: A systematic review of the research evidence. Br J Sports Med. 2005;39:884–91. doi: 10.1136/bjsm.2005.018069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Field T. Yoga clinical research review. Complement Ther Clin Pract. 2011;17:1–8. doi: 10.1016/j.ctcp.2010.09.007. [DOI] [PubMed] [Google Scholar]
  • 48.Hofmann SG, Smits JAJ. Cognitive-behavioral therapy for adult anxiety disorders: A meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry. 2008;69:621–32. doi: 10.4088/jcp.v69n0415. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES